-
Loading metrics
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study
- Christian Wolf,
- Jagdev Sidhu,
- Christian Otoul,
- Dexter L. Morris,
- Jennifer Cnops,
- Jorg Taubel,
- Barbara Bennett
x
- Published: March 5, 2013
- https://doi.org/10.1371/journal.pone.0058438